Analyst Ratings For Charles River Laboratories Intl. (NYSE:CRL)
.
Some recent analyst ratings include
- 2/14/2018-SunTrust Banks Upgrade from a “Hold ” rating to a ” Buy” rating.
- 1/18/2018-Evercore ISI initiated coverage with a In rating.
- 12/13/2017-Argus initiated coverage with a Buy rating.
Recent Insider Trading Activity For Charles River Laboratories Intl. (NYSE:CRL)
Charles River Laboratories Intl. (NYSE:CRL) has insider ownership of 2.20% and institutional ownership of 97.13%.
- On 1/18/2018 Online Communications Bdirect, Director, sold 131,000 with an average share price of $0.29 per share and the total transaction amounting to $37,990.00.
- On 1/2/2018 David Ross Smith, Insider, sold 5,486 with an average share price of $109.53 per share and the total transaction amounting to $600,881.58.
- On 1/2/2018 James C Foster, Chairman, sold 4,967 with an average share price of $109.44 per share and the total transaction amounting to $543,588.48.
- On 1/2/2018 Robert J Bertolini, Director, sold 3,609 with an average share price of $110.22 per share and the total transaction amounting to $397,783.98.
- On 12/12/2017 Kevin Ma, Director, sold 40,384 with an average share price of $0.41 per share and the total transaction amounting to $16,557.44.
- On 12/6/2017 C Richard Reese, Director, sold 10,227 with an average share price of $102.40 per share and the total transaction amounting to $1,047,244.80.
- On 11/10/2017 Bradley Nixon Scharfe, Insider, sold 1,000,000 with an average share price of $0.27 per share and the total transaction amounting to $270,000.00.
Recent Trading Activity for Charles River Laboratories Intl. (NYSE:CRL)
Shares of Charles River Laboratories Intl. closed the previous trading session at 108.87 up +1.21 1.12% with 112.5999984741211 shares trading hands.